Drug Metabolism
DOI: 10.1007/1-4020-4142-x_2
|View full text |Cite
|
Sign up to set email alerts
|

Pathways of Biotransformation — Phase I Reactions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
2
0

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 96 publications
0
2
0
Order By: Relevance
“…These modifications may also be referred to as "phase 1 reactions." 3 Many physicians, however, are most familiar with the role CYP450 proteins can play in pharmacokinetics as direct metabolizers of drugs, conversion of inactive administered compounds to active forms, or as mediators of drug-drug interactions by way of CYP450 induction or suppression. 2 The clinical relevance of CYP450 polymorphisms can be seen in the example of metoprolol metabolism in individuals with variances in CYP2D6 activity.…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…These modifications may also be referred to as "phase 1 reactions." 3 Many physicians, however, are most familiar with the role CYP450 proteins can play in pharmacokinetics as direct metabolizers of drugs, conversion of inactive administered compounds to active forms, or as mediators of drug-drug interactions by way of CYP450 induction or suppression. 2 The clinical relevance of CYP450 polymorphisms can be seen in the example of metoprolol metabolism in individuals with variances in CYP2D6 activity.…”
mentioning
confidence: 99%
“…2 These enzymes perform oxidative, peroxidative, and reductive changes on a variety of endogenous compounds, including steroids, sterols, eicosanoids, uroporphyrinogens, bile acids, vitamin D, retinoids, and saturated and unsaturated fatty acids. These modifications may also be referred to as “phase 1 reactions.” 3 Many physicians, however, are most familiar with the role CYP450 proteins can play in pharmacokinetics as direct metabolizers of drugs, conversion of inactive administered compounds to active forms, or as mediators of drug-drug interactions by way of CYP450 induction or suppression. 2…”
mentioning
confidence: 99%